Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. [electronic resource]
Producer: 20110503Description: 340-6 p. digitalISSN:- 1523-1755
- Aged
- Ambulatory Care -- legislation & jurisprudence
- Anemia -- blood
- Biomarkers -- blood
- Drug Costs
- Drug Utilization -- legislation & jurisprudence
- Erythropoietin -- administration & dosage
- Female
- Health Expenditures -- legislation & jurisprudence
- Health Policy -- economics
- Hematinics -- administration & dosage
- Hemoglobins -- metabolism
- Humans
- Insurance, Health, Reimbursement -- legislation & jurisprudence
- Iron -- administration & dosage
- Japan
- Kidney Failure, Chronic -- blood
- Male
- Middle Aged
- National Health Programs -- economics
- Outcome and Process Assessment, Health Care -- economics
- Practice Guidelines as Topic
- Practice Patterns, Physicians' -- economics
- Prospective Studies
- Recombinant Proteins
- Renal Dialysis -- economics
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.